Sort
89,613 grants matching “depression”
Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein-protein interaction
$1,498,044Stephanie K Florio · Anagin · R44 · FY2018 · NS
20/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT VCU
$1,497,504James M Bjork · Virginia Commonwealth University · U01 · FY2025 · DA
Functional Genomics of Bipolar Disorder
$1,497,299Francis J McMahon · National Institute Of Mental Health · ZIA · FY2016 · MH
Identification of Genes Involved in Major Mood Disorders
$1,497,299Francis J McMahon · National Institute Of Mental Health · ZIA · FY2016 · MH
Translation of comparative effectiveness of depression medications into practice
$1,496,528Victor Manuel Montori · Mayo Clinic Rochester · R18 · FY2010 · HS
CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo Imaging
$1,496,457Ann Carolyn McKee · Boston University Medical Campus · U01 · FY2016 · NS
Neurobehavioral Changes in Pediatric Affective Disorder
$1,494,999University Of Pittsburgh At Pittsburgh · P01 · FY2005 · MH
Using GWAS Data for Enhanced Mendelian Randomization Studies
$1,494,822Laura D Kubzansky · Harvard School Of Public Health · RC4 · FY2010 · MH
Neural Substrates of Reward Processing and Emotion
$1,494,771Elisabeth A Murray · National Institute Of Mental Health · ZIA · FY2016 · MH
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
$1,494,231Yukari C Manabe · Johns Hopkins University · U54 · FY2022 · EB
TOPIC 342 - PHASE II CONTRACT - VALIDATION OF SHADE A MOBILE TECHNOLOGY FOR MONITORING OF ULTRAVIOLET EXPOSUREPOP - 1/20/2017 - 1/19/2019
$1,494,124Emmanuel Dumont · Youv Labs, Inc. · N44 · FY2017 · CA
Social-Emotional Contexts of Adolescent Smoking Patterns
$1,494,084Robin J Mermelstein · University Of Illinois At Chicago · P01 · FY2007 · CA
Chemical Coding Of Neurotransmission
$1,493,463Lee E. Eiden · National Institute Of Mental Health · ZIA · FY2010 · MH
UAB-MISS WIHS Cohort
$1,493,020Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2014 · AI
A Phase 3 clinical trial of an e-health behavioral intervention to improve executive functioning in adolescents with epilepsy
$1,492,982Avani C Modi · Cincinnati Childrens Hosp Med Ctr · UG3 · FY2024 · NS
Subunit-Specific Regulation Of Glutamate Receptors
$1,492,766Katherine Roche · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias
$1,492,444Anumantha Gounder Kanthasamy · University Of Georgia · U01 · FY2024 · AG
Impact of Depression on Alzheimer's disease: Prenatal Immune Origins and Shared Impact of Sex
$1,492,211Jill M Goldstein · Massachusetts General Hospital · R01 · FY2019 · AG
Accounting for confounding bias and heterogeneity in comparative effectiveness
$1,492,184Alistair James O'Malley · Harvard Medical School · RC4 · FY2010 · MH
PROsetta Stone
$1,492,049David Cella · Northwestern University At Chicago · RC4 · FY2010 · CA
A Pragmatic Trial of Parent-focused Prevention in Pediatric Primary Care
$1,492,001Margaret Kuklinski · University Of Washington · UH3 · FY2020 · AT
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study
$1,491,998Joe Verghese · Albert Einstein College Of Medicine · R01 · FY2023 · AG
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
$1,491,977Xinmin Simon Xie · Afasci, Inc. · R44 · FY2018 · NS
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
$1,491,584Xinmin Simon Xie · Afasci, Inc. · R44 · FY2020 · NS
The Proactive Screening and diagnosis of mild cognitive impairment and depression in patients aged 65 and over: An Implementation Study
$1,491,441Shenly Glenn · Miro Health Inc · R44 · FY2022 · AG